发明名称 Carrier-linked magnetic nanoparticle drug delivery composition and method of use
摘要 The present invention is a targeted drug delivery composition composed of carrier-linked magnetic nanoparticles. Using an alternating magnetic field, nanoparticles bound to a targeted cell are selectively ruptured thereby releasing therapeutic agents at the desired site of action.
申请公布号 US9211346(B2) 申请公布日期 2015.12.15
申请号 US201113993359 申请日期 2011.12.01
申请人 TRUSTEES OF DARTMOUTH COLLEGE 发明人 Weaver John B.
分类号 A61K9/14;A61K47/48;A61K9/00;A61K41/00;B82Y5/00;B82Y25/00;A61K9/127;A61M37/00 主分类号 A61K9/14
代理机构 Licata & Tyrrell P.C. 代理人 Licata & Tyrrell P.C.
主权项 1. A method for providing a therapeutic agent to a subject comprising administering to a subject in need thereof a carrier-linked magnetic nanoparticle containing a therapeutic agent and a targeting moiety attached to the carrier-linked magnetic nanoparticle, wherein the carrier is a liposome and the therapeutic agent is encapsulated within the carrier-linked magnetic nanoparticle, and wherein the application of an alternating magnetic field to the subject causes liposomes bound to a target cell in the subject to rupture and release therapeutic agent, while unbound liposomes remain intact, thereby providing the therapeutic agent to the subject.
地址 Hanover NH US